Genelux (GNLX) EBIT Margin (2022 - 2024)

Genelux's EBIT Margin history runs 3 years deep, the most recent figure standing at 101437.5% for Q1 2024.

• On a quarterly basis, EBIT Margin fell 9763632.0% year-over-year to 101437.5% in Q1 2024; TTM through Dec 2024 was 396200.0%, a 38198529.0% decrease from a year earlier, with the FY2025 full-year figure at 415175.0%, down 1897500.0% from the prior year.
• EBIT Margin slipped to 101437.5% in Q1 2024 per GNLX's latest filing, from 3801.18% in the prior quarter.
• Across five years, EBIT Margin topped out at 57.67% in Q3 2022 and bottomed at 101437.5% in Q1 2024.
• The 3-year median for EBIT Margin is 1886.3% (2022), against an average of 26288.11%.
• Biggest YoY gain for EBIT Margin was 9763632 bps in 2024; the steepest drop was 9763632 bps in 2024.
• Year by year, EBIT Margin stood at 28.57% in 2022, then plunged by 13405 bps to 3801.18% in 2023, then sank by 2569 bps to 101437.5% in 2024.
• Per Business Quant, the three latest GNLX EBIT Margin figures stand at 101437.5% (Q1 2024), 3801.18% (Q1 2023), and 28.57% (Q4 2022).